The COVID-19 vaccine developed by Pfizer-BioNTech received emergency use authorization in December 2020.
**Cycle ID:** `cycle_9458_cyc_9458_1ea78a15` **Verified at:** 2026-04-12T21:12:20.875Z **Ensemble:** 9 models from 3 providers **Result:** 9 of 9 models responded **Cycle wall time:** 16.91 seconds **Canonical URL:** https://trust.polylogicai.com/claim/the-covid-19-vaccine-developed-by-pfizer-biontech-received-emergency-use-authori **Source paper:** [PolybrainBench (version 12)](https://trust.polylogicai.com/polybrainbench) **Source ledger row:** [`public-ledger.jsonl#cycle_9458_cyc_9458_1ea78a15`](https://huggingface.co/datasets/polylogic/polybrainbench/blob/main/public-ledger.jsonl) **Cryptographic provenance:** SHA-256 `a0384ac7cda6781cf0133f4711388c3d59c0a379383366a8b08d5a3e6d06e885`
Verification verdict
Of 9 models in the ensemble, 9 responded successfully and 0 failed.
Per-model responses
The full text of each model's response is available in the source ledger. The summary below records each model's success or failure and the first 280 characters of its response.
| Model | Status | Response chars | | --- | :---: | ---: | | gpt-4.1-mini | ✓ | 1276 | | gpt-4.1-nano | ✓ | 3528 | | gpt-oss-120b | ✓ | 1326 | | grok-3-mini | ✓ | 6329 | | grok-4-fast | ✓ | 6522 | | kimi-k2-groq | ✓ | 228 | | llama-3.3-70b | ✓ | 3110 | | llama-4-scout | ✓ | 1233 | | qwen3-32b | ✓ | 6494 |
Pairwise agreement
The pairwise Jaccard agreement between successful responses for this cycle:
_Per-cycle pairwise agreement matrix is computed offline; will be populated in canonical page v2._
Divergence score
This cycle's divergence score is **TBD** on a 0 to 1 scale, where 0 means all responses are token-identical and 1 means no two responses share any tokens. The dataset-wide median divergence is 0.5 for context.
How to cite this claim
```bibtex @misc{polybrainbench_claim_cycle_9458_cyc_9458_1ea78a15, author = {Polylogic AI}, title = {The COVID-19 vaccine developed by Pfizer-BioNTech received emergency use authorization in December 2020.}, year = {2026}, howpublished = {PolybrainBench cycle cycle_9458_cyc_9458_1ea78a15}, url = {https://trust.polylogicai.com/claim/the-covid-19-vaccine-developed-by-pfizer-biontech-received-emergency-use-authori} } ```
Reproduce this cycle
```bash node ~/polybrain/bin/polybrain-cycle.mjs start --raw --fast "The COVID-19 vaccine developed by Pfizer-BioNTech received emergency use authorization in December 2020." ```
Schema.org structured data
```json { "@context": "https://schema.org", "@type": "ClaimReview", "datePublished": "2026-04-12T21:12:20.875Z", "url": "https://trust.polylogicai.com/claim/the-covid-19-vaccine-developed-by-pfizer-biontech-received-emergency-use-authori", "claimReviewed": "The COVID-19 vaccine developed by Pfizer-BioNTech received emergency use authorization in December 2020.", "itemReviewed": { "@type": "Claim", "datePublished": "2026-04-12T21:12:20.875Z", "appearance": "https://trust.polylogicai.com/claim/the-covid-19-vaccine-developed-by-pfizer-biontech-received-emergency-use-authori", "author": { "@type": "Organization", "name": "PolybrainBench" } }, "reviewRating": { "@type": "Rating", "ratingValue": "9", "bestRating": "9", "worstRating": "0", "alternateName": "Unanimous" }, "author": { "@type": "Organization", "name": "Polylogic AI", "url": "https://polylogicai.com" } } ```
Provenance and integrity
This page was generated by the PolybrainBench daemon at version 0.1.0 from cycle cycle_9458_cyc_9458_1ea78a15. The full provenance chain (per-response SHA-256 stamps, cross-cycle prev-hash linking, Thalamus grounding verification) is recorded in the source cycle directory at `~/polybrain/cycles/9458/provenance.json` and mirrored in the published dataset. The page is regenerated on every harvest pass; the URL is permanent and the content is immutable for any given paper version.
Source: PolybrainBench paper v8, DOI 10.5281/zenodo.19546460
License: CC-BY-4.0
Verified by: 9-model ensemble across OpenAI, xAI, Groq, Moonshot
Canonical URL: https://polylogicai.com/trust/claim/the-covid-19-vaccine-developed-by-pfizer-biontech-received-emergency-use-authori